Nicolaas Schaap Selected Research

Nicolaas Schaap Research Topics

Disease

25	Neoplasms (Cancer) 12/2023 - 02/2010
15	Multiple Myeloma 11/2023 - 03/2010
12	Leukemia 11/2023 - 11/2010
11	Primary Myelofibrosis (Myelosclerosis) 12/2023 - 07/2017
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 03/2015
6	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2011
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 02/2013
3	Myeloid Leukemia (Leukemia, Myelocytic) 01/2013 - 08/2011
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 10/2017
2	Lymphoma (Lymphomas) 01/2018 - 10/2017
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 03/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022
1	Bacterial Infections (Bacterial Infection) 06/2022
1	Cytopenia 06/2020
1	Splenomegaly 06/2020
1	Disease Progression 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2019
1	Thrombocytopenia (Thrombopenia) 10/2019
1	Blast Crisis (Blast Phase) 10/2019
1	Carcinoma (Carcinomatosis) 02/2019
1	Ovarian Neoplasms (Ovarian Cancer) 02/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2018
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 07/2017
1	Residual Neoplasm 06/2016
1	Infections 05/2014
1	Virus Diseases (Viral Diseases) 02/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2012

Drug/Important Bio-Agent (IBA)

8	Minor Histocompatibility AntigensIBA 01/2018 - 11/2010
7	ruxolitinibIBA 01/2022 - 07/2017
6	fedratinibIBA 01/2022 - 07/2017
6	16-iodo-3-methylhexadecanoic acid (MIHA)IBA 01/2018 - 11/2010
3	Janus Kinase InhibitorsIBA 01/2022 - 06/2020
3	AntigensIBA 10/2016 - 02/2013
2	Melphalan (Alkeran)FDA LinkGeneric 11/2023 - 01/2018
2	Busulfan (Busulfex)FDA Link 11/2023 - 01/2020
2	VaccinesIBA 01/2017 - 11/2010
2	Messenger RNA (mRNA)IBA 08/2013 - 02/2013
2	Small Interfering RNA (siRNA)IBA 02/2013 - 11/2010
2	LigandsIBA 07/2012 - 08/2011
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023
1	Etoposide (VP 16)FDA LinkGeneric 11/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	carfilzomibIBA 11/2023
1	Lenalidomide (CC 5013)FDA Link 11/2023
1	cyclo(Arg-Pro) (CI 4)IBA 06/2022
1	Core Binding Factor Alpha 2 SubunitIBA 10/2021
1	Immunoglobulin M (IgM)IBA 10/2021
1	Immunoglobulin D (IgD)IBA 10/2021
1	Janus Kinase 2IBA 05/2021
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 06/2020
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 06/2020
1	fludarabineIBA 01/2020
1	plerixafor FDA Link 01/2020
1	ibrutinibIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 10/2019
1	Sorafenib (BAY 43-9006)FDA Link 03/2019
1	Blocking AntibodiesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	InterferonsIBA 12/2015
1	B-Cell Maturation AntigenIBA 08/2013
1	SurvivinIBA 08/2013
1	DNA (Deoxyribonucleic Acid)IBA 02/2013
1	Interleukin-15 (Interleukin 15)IBA 01/2013
1	AntibodiesIBA 08/2011
1	CytokinesIBA 11/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2010

Therapy/Procedure

31	Stem Cell Transplantation 11/2023 - 03/2010
10	Transplantation 01/2020 - 03/2015
8	Immunotherapy 06/2022 - 02/2010
7	Therapeutics 12/2021 - 11/2014
5	Drug Therapy (Chemotherapy) 11/2023 - 01/2013
4	Cell Transplantation 12/2023 - 10/2017
3	Hematopoietic Stem Cell Transplantation 12/2021 - 01/2018
2	Autologous Transplantation 01/2018 - 01/2018
1	Salvage Therapy 01/2020
1	Hematopoietic Stem Cell Mobilization 01/2020
1	Duration of Therapy 10/2019
1	Parenteral Infusions 02/2019
1	Kidney Transplantation 01/2019
1	Ligation 01/2018
1	Homologous Transplantation 12/2015